MILIND JAVLE to Radiotherapy, Adjuvant
This is a "connection" page, showing publications MILIND JAVLE has written about Radiotherapy, Adjuvant.
Connection Strength
0.179
-
Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma. Cancer J. 2007 Mar-Apr; 13(2):119-24.
Score: 0.050
-
Management of locoregional stage esophageal cancer: a single center experience. Dis Esophagus. 2006; 19(2):78-83.
Score: 0.046
-
Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients? Dis Esophagus. 2004; 17(2):129-35.
Score: 0.040
-
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. J Clin Oncol. 2011 Aug 01; 29(22):3037-43.
Score: 0.017
-
Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. Ann Surg Oncol. 2011 Dec; 18(13):3615-22.
Score: 0.017
-
Should adjuvant therapy remain the standard of care for patients with resected adenocarcinoma of the pancreas? Ann Surg Oncol. 2003 Jun; 10(5):539-45.
Score: 0.010